The upcoming Quarterly will be pivotal.The company has been...

The upcoming Quarterly will be pivotal.

The company has been pursuing it's strategy of fast tracking revenue for the previous year and a half or so - and it is succeeding. I will be interested to see what contribution Sierra Sage Herbs and ImpActive made last quarter - they are the missing links at this stage. And the export of psilocybin to the new Australian clinics that are being set up is still pending.

The way I see it, the market is pleased with the revenue increases but is still sitting on the side lines until expenses are disclosed. If management can deliver on it's commitment to reduce costs and keep expenses under $2.5 - 3 million for the quarter then we're off to the races imo ! If not, then it's a matter of more quarters to continue improving the balance sheet as Melodiol moves in the right direction.

Debt is only a few million and will easily be serviced by small profit gains. Then, further down the track, I would like to see a share buyback while the share price is cheap.

GLTAH !